Free Trial
CVE:VM

Voyageur Pharmaceuticals (VM) Stock Price, News & Analysis

Voyageur Pharmaceuticals logo
C$0.17 +0.01 (+6.25%)
As of 05/23/2025 01:19 PM Eastern

About Voyageur Pharmaceuticals Stock (CVE:VM)

Key Stats

Today's Range
C$0.17
C$0.17
50-Day Range
C$0.15
C$0.20
52-Week Range
C$0.04
C$0.25
Volume
14,000 shs
Average Volume
195,476 shs
Market Capitalization
C$25.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.

Receive VM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Voyageur Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

VM Stock News Headlines

52 Money Mondays for $7 (This Weekend Only)
Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’s “Most Wanted” trader, who just put the finishing touches on his brand-new Money Monday algorithm.
See More Headlines

VM Stock Analysis - Frequently Asked Questions

Voyageur Pharmaceuticals' stock was trading at C$0.09 on January 1st, 2025. Since then, VM shares have increased by 100.0% and is now trading at C$0.17.
View the best growth stocks for 2025 here
.

Shares of VM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Voyageur Pharmaceuticals investors own include GFG Resources (GFG), Pine Cliff Energy (PNE), Tamarack Valley Energy (TVE), Caladrius Biosciences (CLBS), Capstone Copper (CS), Calibre Mining (CXB) and Mawson Gold (MAW).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:VM
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-1,664,938.27
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.00 per share
Price / Cash Flow
35.00
Book Value
C$0.01 per share
Price / Book
25.09

Miscellaneous

Free Float
N/A
Market Cap
C$25.76 million
Optionable
Not Optionable
Beta
0.32
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (CVE:VM) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners